Pregnant/Post-Partum Women & Their Infants

Discusses how screening, brief intervention, and referral to treatment can be conducted by nurse practitioners in primary care; offers 1 CE credit

Presents information on alcohol use in women and using SBIRT and brief motivational interviewing; includes step-by-step examples on using this approach

The purpose of this resource guide is to share practical strategies and resources implemented by the Neonatal Abstinence Syndrome (NAS) Investment Program awardees for addressing opioid use disorder (OUD) stigma in hospitals treating pregnant and parenting women with OUD.

Designed for people who work in health-related fields, this interactive site will help you learn how stigma can impact the healthcare and support women need, seek and receive.

This toolkit introduces best practices to support and improve the quality of care for substance exposed mothers and newborns.

This toolkit focuses on structural stigma oriented toward health care professionals and systems-based approaches.

This NIDA policy brief shares evidence-based research on treating opioud use dissorder on pregnancy, including the assessment of methadone and buprenorphine as treatment.

This CDC page provides an overview of how opioid use impacts pregancy to help women who use opioids during pregnancy be aware of the possible risks and potential treatment options for opioid use disorder.

These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which assist women who are pregnant, or have recently had a child, and who use alcohol or drugs or who have a substance use disorder.

This brief describes the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model for pregnant and postpartum women with substance use disorders and how to implement and integrate SBIRT into care delivery.